Integra Lifesciences (IART) Tops Q2 EPS by 4c

Integra Lifesciences (NASDAQ: IART) reported Q2 EPS of $0.68, $0.04 better than the analyst estimate of $0.64. Revenue for the quarter came in at $231.4 million versus the consensus estimate of $229.32 million.

For earnings history and earnings-related data on Integra Lifesciences (IART) click here.

You May Also Be Interested In

• Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
• Highwoods Properties (HIW) Tops Q1 EPS by 6c, provides guidance
• Renasant Corp. (RNST) Tops Q1 EPS by 3c